- Home
- PODC vs VNRX Comparison
PODC vs VNRX Comparison
Compare PODC & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PODC
- VNRX
- Stock Information
- Founded
- PODC 2013
- VNRX N/A
- Country
- PODC United States
- VNRX United States
- Employees
- PODC N/A
- VNRX N/A
- Industry
- PODC
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- PODC
- VNRX Health Care
- Exchange
- PODC Nasdaq
- VNRX Nasdaq
- Market Cap
- PODC 44.1M
- VNRX 52.4M
- IPO Year
- PODC N/A
- VNRX N/A
- Fundamental
- Price
- PODC $1.98
- VNRX $0.53
- Analyst Decision
- PODC Strong Buy
- VNRX Strong Buy
- Analyst Count
- PODC 1
- VNRX 4
- Target Price
- PODC $5.00
- VNRX $4.17
- AVG Volume (30 Days)
- PODC 12.2K
- VNRX 273.7K
- Earning Date
- PODC 06-10-2025
- VNRX 05-15-2025
- Dividend Yield
- PODC N/A
- VNRX N/A
- EPS Growth
- PODC N/A
- VNRX N/A
- EPS
- PODC N/A
- VNRX N/A
- Revenue
- PODC $49,729,000.00
- VNRX $1,308,361.00
- Revenue This Year
- PODC $20.67
- VNRX $563.72
- Revenue Next Year
- PODC $19.09
- VNRX $160.43
- P/E Ratio
- PODC N/A
- VNRX N/A
- Revenue Growth
- PODC 22.98
- VNRX 64.16
- 52 Week Low
- PODC $1.10
- VNRX $0.40
- 52 Week High
- PODC $2.85
- VNRX $0.90
- Technical
- Relative Strength Index (RSI)
- PODC 51.42
- VNRX 57.40
- Support Level
- PODC $1.87
- VNRX $0.40
- Resistance Level
- PODC $2.12
- VNRX $0.54
- Average True Range (ATR)
- PODC 0.16
- VNRX 0.05
- MACD
- PODC -0.01
- VNRX 0.01
- Stochastic Oscillator
- PODC 50.75
- VNRX 75.12
About PODC PodcastOne Inc.
PodcastOne Inc is a podcast platform and publisher that makes its content available to audiences via all podcasting distribution platforms, including its website, its PodcastOne app, Apple Podcasts, Spotify, Amazon Music, and more.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.